Will Run 3 Be Updated

[Carlito Roby]

NoteInformation in this article was accurate at the time of original publication. Because information about COVID-19 changes rapidly, we encourage you to visit the websites of the Centers for Disease Control & Prevention (CDC), World Health Organization (WHO), and your state and local government for the latest information.

The Food and Drug Administration (FDA) authorized the updated vaccines by Pfizer-BioNTech and Moderna for infants and children ages 6 months to 11 years, and approved them for everyone ages 11 years and older. It also authorized an updated Novavax vaccine for those 12 and older in the fall of 2023.

The updated vaccines are not expected to prevent all cases of COVID, including those causing mild illness; rather, their aim is to reduce severe illness, hospitalization, and death from infection. According to the CDC, COVID is still a major cause of serious respiratory illness. While hospitalizations and deaths from COVID have been declining, 7,318 people were hospitalized with the disease during the first week of April 2024 alone (that number rose as high as 35,000 during one week in January, a month when respiratory diseases tend to peak).

Older people (especially those ages 50 and older) are more likely than younger people to get very sick from COVID. Immunocompromised people and those with chronic medical conditions, such as diabetes or heart disease, are at the highest risk of severe disease and death, but some young, healthy people have also gotten very ill and died from COVID. In addition, the CDC recommends the vaccine for pregnant women to protect both mother and baby.

The bivalent booster, which is no longer available, was introduced in the fall of 2022. It targeted the BA.4 and BA.5 Omicron subvariants and the original SARS-CoV-2 virus. The updated vaccine is monovalent, designed to prevent severe disease from the Omicron XBB.1.5 subvariant. By September 2023, the long-running XBB.1.5 accounted for only about 3% of cases in the U.S., but most of the strains circulating now are descended from (or closely related to) it.

COVID vaccines are safe and effective, according to the CDC. The safety of COVID vaccines has been rigorously monitored and evaluated since their emergency use authorization (EUA) in December 2020. According to the CDC, the updated mRNA COVID vaccines for 2023-2024 are manufactured using a similar process to the previous vaccines.

The benefits of the COVID vaccine continue to outweigh any potential risks, and serious reactions after COVID vaccination are rare, according to the CDC. The agency cited a study showing the risk of cardiac complications, including myocarditis (an inflammation of the heart muscle) was significantly higher after a COVID infection for both males and females in all age groups.

The FDA authorized an updated version of a vaccine Novavax developed to target the XBB.1.5 strain. Individuals 12 and older previously vaccinated with a COVID vaccine (and who have not already been vaccinated with a recently updated mRNA COVID vaccine) are eligible to receive one dose; unvaccinated individuals can receive two doses.

People 5 years and older may get one dose of the updated vaccine at least two months after the last dose of any previous COVID vaccine. Babies and young children usually need more doses than older children and teens. Anyone who recently had COVID may consider delaying their vaccine by 3 months.

As with previous COVID vaccines, this one will be available at participating pharmacies and provider offices. To find a location near you that carries the vaccine and to schedule an appointment, go to Vaccines.gov. You can also call 1-800-232-0233 (TTY 1-888-720-7489). Be aware that current distribution and insurance issues may delay availability of the vaccines temporarily in some places.

According to the CDC, the vaccines are covered by insurance, including private insurance, Medicare plans, and Medicaid plans. Uninsured children and uninsured adults also have access through the Vaccine for Children Program and Bridge Access Program, respectively.

Information provided in Yale Medicine articles is for general informational purposes only. No content in the articles should ever be used as a substitute for medical advice from your doctor or other qualified clinician. Always seek the individual advice of your health care provider with any questions you have regarding a medical condition.

We would like to provide you with an important update regarding the 2024-25 Free Application for Federal Student Aid (FAFSA) process. This Electronic Announcement provides further details regarding aid eligibility and the post-processing experience for students, institutions, state higher education agencies, and scholarship organizations.

As part of our continuing commitment to put students first, we will ensure students and their families receive all the aid they are entitled to receive. To account for inflationary adjustments as required under the law, the Department has updated the supporting tables used in the Student Aid Index (SAI) calculation, ensuring that students are benefitting from approximately an additional $1.8 billion in aid. These tables, which directly impact eligibility for need-based federal student aid, detail the allowances against income and assets reported by students and families on their FAFSA form. The revised tables are included in the final Student Aid Index (SAI) and Pell Grant Eligibility Guide. In the coming weeks, our teams will be updating the Federal Processing System (FPS) to include the updated tables. Based upon estimations for completing that work, the Department will begin transmitting batches of FAFSA information (ISIRs) to schools and state agencies in the first half of March, which will include the updated SAI tables. We anticipate catching up with the majority of ISIR transmissions to schools in the weeks following the beginning of ISIR delivery.

Students will be able to make corrections to their FAFSA once their eligibility has been calculated and ISIR generated. Students may view their eligibility calculation by logging back into their Studentaid.gov account.

Institutions, state higher ed agencies, and designated scholarship organizations will begin receiving batches of FAFSA information (ISIRs) starting in the first half of March. The information transmitted to schools will include the updated SAI tables.

As in previous years, when the Congressional appropriations process has completed and determined the 2024-25 Maximum Federal Pell Grant award amount, ISIRs will be re-processed to reflect that update.

Hi @BiancaT

How are we travelling on this one, the reason I ask is because I have to deploy our template to all customer records (folders) and a bit apprehensive about doing this before this change is implemented. Thanks

Potential New User here. Testing the waters today.

One of the first must haves I realized I would need is some kind of auto update project boards based on the standing template. Realized this was not happening and found this thread. Is there some kind of ETA on this?

What steps can the community take to express how important this is and to raise the priority on this topic? Do we need to start a campaign to get others to attach themselves to this feature? Seeing in the comments that this goes back 4 years is a bit concerning to new users who really need this feature. There was also a comment I saw somewhere that this would only be available on Enterprise - if so then this feature will never be available to my team.

FinCEN has prepared the following Frequently Asked Questions (FAQs) in response to inquiries received relating to the Beneficial Ownership Information Reporting Rule and Beneficial Ownership Information Access and Safeguards Rule.

FinCEN published the rule that will govern access to and protection of beneficial ownership information on December 22, 2023. Beneficial ownership information reported to FinCEN will be stored in a secure, non-public database using rigorous information security methods and controls typically used in the Federal government to protect non-classified yet sensitive information systems at the highest security level. FinCEN will work closely with those authorized to access beneficial ownership information to ensure that they understand their roles and responsibilities in using the reported information only for authorized purposes and handling in a way that protects its security and confidentiality.

FinCEN is engaged in a robust outreach and education campaign to raise awareness of and help reporting companies understand the new reporting requirements. That campaign involves virtual and in-person outreach events and comprehensive guidance in a variety of formats and languages, including multimedia content and the Small Entity Compliance Guide, as well as new channels of communication, including social media platforms. FinCEN is also engaging with governmental offices at the federal and state levels, small business and trade associations, and interest groups.

FinCEN will continue to provide guidance, information, and updates related to the BOI reporting requirements on its BOI webpage, www.fincen.gov/boi. Subscribe here to receive updates via email from FinCEN about BOI reporting obligations.

No. FinCEN expects that many, if not most, reporting companies will be able to submit their beneficial ownership information to FinCEN on their own using the guidance FinCEN has issued. Reporting companies that need help meeting their reporting obligations can consult with professional service providers such as lawyers or accountants.

Yes, 23 types of entities are exempt from the beneficial ownership information reporting requirements. These entities include publicly traded companies meeting specified requirements, many nonprofits, and certain large operating companies.

It depends. A domestic entity such as a statutory trust, business trust, or foundation is a reporting company only if it was created by the filing of a document with a secretary of state or similar office. Likewise, a foreign entity is a reporting company only if it filed a document with a secretary of state or a similar office to register to do business in the United States.

3a8082e126